Icon Plc (ICLR)

$98.33 +0.88 (0.90%)
Market Cap 7.94B
Revenue (ttm) 8.28B
Net Income (ttm) 791.47M
EPS (ttm) N/A
PE Ratio 7.88
Forward PE 8.36
Profit Margin 9.56%
Debt to Equity Ratio 0.37
Volume 970,200
Avg Vol 2,049,542
Day's Range N/A - N/A
Shares Out 80.76M
Stochastic %K 8%
Beta 1.35
Analysts Sell
Price Target $135.77

Company Profile

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and p...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 353 1 291 2000
Fax: 353 1 247 6260
Address:
South County Business Park, Leopardstown, Dublin, Ireland
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 13 at 1:01 PM
$ICLR RSI: 46.96, MACD: -11.2775 Vol: 8.03, MA20: 102.24, MA50: 147.68 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
erevnon
erevnon Mar. 11 at 4:07 PM
Citigroup maintains Icon $ICLR at Neutral and lowers the price target from $200 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
anachartanalyst
anachartanalyst Mar. 9 at 3:02 PM
$ICLR https://anachart.com/wp-content/uploads/ana_temp/1773068494_soc-img.jpg
0 · Reply
Rogue23
Rogue23 Mar. 6 at 5:33 PM
$ICLR Earnings today?
0 · Reply
2sexyBiatch
2sexyBiatch Mar. 6 at 6:22 AM
$ICLR still waiting for $150
0 · Reply
sandeeprk
sandeeprk Feb. 23 at 4:49 PM
$ICLR steadily and slowly it will reach 160+
0 · Reply
PittsburghTrader
PittsburghTrader Feb. 23 at 4:28 PM
$ICLR back > $100, nice… that crash on small acctg issue was certainly nice buying opportunity
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 20 at 3:01 AM
$ICLR Share Price: $98.27 Contract Selected: Jul 17, 2026 $100 Calls Buy Zone: $11.81 – $14.60 Target Zone: $20.32 – $24.83 Potential Upside: 62% ROI Time to Expiration: 147 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 19 at 7:48 PM
$ICLR RSI: 20.84, MACD: -23.4293 Vol: 38.53, MA20: 149.76, MA50: 170.62 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
apux
apux Feb. 19 at 5:55 PM
$ICLR - why does it feel like this should be getting a buyout offer at $180 right now?
0 · Reply
Latest News on ICLR
Ademi LLP Investigates Claims of Securities Fraud against ICON plc

Feb 26, 2026, 9:06 AM EST - 17 days ago

Ademi LLP Investigates Claims of Securities Fraud against ICON plc

ICLR Investors Have Opportunity to Join ICON Public Limited Company Fraud Investigation with the Schall Law Firm

Feb 25, 2026, 9:52 AM EST - 18 days ago

ICLR Investors Have Opportunity to Join ICON Public Limited Company Fraud Investigation with the Schall Law Firm

ICON plc Faces Investigation After Internal Probe Reveals Multi-Year Revenue Overstatement

Feb 18, 2026, 9:00 AM EST - 25 days ago

ICON plc Faces Investigation After Internal Probe Reveals Multi-Year Revenue Overstatement

Diamond Hill International Strategy Q4 2025 Portfolio Review

Feb 17, 2026, 2:14 AM EST - 26 days ago

Diamond Hill International Strategy Q4 2025 Portfolio Review

BABA NWG QURE

ICON plc (ICLR) Shares Crater Amid Delayed Financial Report, Investigation Into Revenue Recognition Issues - Hagens Berman

Feb 13, 2026, 8:14 AM EST - 4 weeks ago

ICON plc (ICLR) Shares Crater Amid Delayed Financial Report, Investigation Into Revenue Recognition Issues - Hagens Berman

ICON plc (ICLR) Shares Crater Amid Delayed Financial Report, Investigation Into Revenue Recognition Issues – Hagens Berman

Feb 12, 2026, 4:32 PM EST - 4 weeks ago

ICON plc (ICLR) Shares Crater Amid Delayed Financial Report, Investigation Into Revenue Recognition Issues – Hagens Berman

Why this drug-research company's stock is having its worst day since 1999

Feb 12, 2026, 11:10 AM EST - 4 weeks ago

Why this drug-research company's stock is having its worst day since 1999

ICON PLC (ICLR) Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Feb 12, 2026, 10:15 AM EST - 4 weeks ago

ICON PLC (ICLR) Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

ICLR Down 30%: ICON plc Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm

Feb 12, 2026, 8:56 AM EST - 4 weeks ago

ICLR Down 30%: ICON plc Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm

ICON plc Provides Update on Timing of Fourth Quarter and Full Year 2025 Earnings Results and Investigation into Accounting Practices

Feb 12, 2026, 6:00 AM EST - 4 weeks ago

ICON plc Provides Update on Timing of Fourth Quarter and Full Year 2025 Earnings Results and Investigation into Accounting Practices

ICON's Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership

Jan 27, 2026, 7:15 AM EST - 6 weeks ago

ICON's Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership

GreensKeeper Value Fund Q4 2025 Portfolio Update: Long-Term Winners

Jan 26, 2026, 10:30 PM EST - 6 weeks ago

GreensKeeper Value Fund Q4 2025 Portfolio Update: Long-Term Winners

A ADBE AXP B C CBOE CHKP

ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive

Dec 9, 2025, 7:15 AM EST - 3 months ago

ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive

ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions

Dec 2, 2025, 7:15 AM EST - 3 months ago

ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions

ICON Public Limited Company (ICLR) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 20, 2025, 4:43 PM EST - 4 months ago

ICON Public Limited Company (ICLR) Presents at Jefferies London Healthcare Conference 2025 Transcript

ICON plc to Present at the Jefferies London Healthcare Conference

Nov 12, 2025, 6:45 AM EST - 4 months ago

ICON plc to Present at the Jefferies London Healthcare Conference

Invesco International Small-Mid Company Fund Q3 2025 Top Contributors And Detractors

Nov 5, 2025, 3:59 AM EST - 4 months ago

Invesco International Small-Mid Company Fund Q3 2025 Top Contributors And Detractors

ICON Public Limited Company (ICLR) Q3 2025 Earnings Call Transcript

Oct 23, 2025, 2:07 PM EDT - 5 months ago

ICON Public Limited Company (ICLR) Q3 2025 Earnings Call Transcript

ICON Reports Third Quarter 2025 Results

Oct 22, 2025, 4:25 PM EDT - 5 months ago

ICON Reports Third Quarter 2025 Results

ICON: Solid Fundamentals Trump Regulatory Headwinds

Oct 22, 2025, 4:38 AM EDT - 5 months ago

ICON: Solid Fundamentals Trump Regulatory Headwinds

ICON plc Schedules Third Quarter 2025 Earnings Conference Call

Sep 24, 2025, 9:00 AM EDT - 6 months ago

ICON plc Schedules Third Quarter 2025 Earnings Conference Call

ICON Announces CEO Transition

Sep 4, 2025, 8:00 AM EDT - 6 months ago

ICON Announces CEO Transition

ICON plc to Participate at Upcoming Investor Conferences

Sep 2, 2025, 6:00 AM EDT - 6 months ago

ICON plc to Participate at Upcoming Investor Conferences

ICON Public Limited Company (ICLR) Q2 2025 Earnings Call Transcript

Jul 24, 2025, 6:21 PM EDT - 8 months ago

ICON Public Limited Company (ICLR) Q2 2025 Earnings Call Transcript

ICON Stock Up After Q2 Results Signal Growing Confidence In Biopharma Recovery

Jul 24, 2025, 2:01 PM EDT - 8 months ago

ICON Stock Up After Q2 Results Signal Growing Confidence In Biopharma Recovery

ICON: Lower Guidance Downside And Expanded Repurchase Plan

Jul 24, 2025, 7:00 AM EDT - 8 months ago

ICON: Lower Guidance Downside And Expanded Repurchase Plan

ICON Announces Results of Annual General Meeting

Jul 23, 2025, 4:20 PM EDT - 8 months ago

ICON Announces Results of Annual General Meeting

ICON Reports Second Quarter 2025 Results

Jul 23, 2025, 4:15 PM EDT - 8 months ago

ICON Reports Second Quarter 2025 Results

ICON's Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report

Jul 16, 2025, 7:15 AM EDT - 8 months ago

ICON's Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report

ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability

Jul 7, 2025, 7:15 AM EDT - 8 months ago

ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability

ICON: With A 57% Drop, Trump Legislation, And Debt Reduction, Is The Stock Undervalued?

Jun 25, 2025, 6:36 AM EDT - 9 months ago

ICON: With A 57% Drop, Trump Legislation, And Debt Reduction, Is The Stock Undervalued?

ICON plc Schedules Second Quarter 2025 Earnings Conference Call

Jun 23, 2025, 6:30 AM EDT - 9 months ago

ICON plc Schedules Second Quarter 2025 Earnings Conference Call

ICLR Shareholders Have the Right to Lead the ICON Public Limited Company Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ICLR

Jun 2, 2025, 4:12 AM EDT - 10 months ago

ICLR Shareholders Have the Right to Lead the ICON Public Limited Company Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ICLR

ICON plc to Present at the William Blair 45th Annual Growth Stock Conference

May 27, 2025, 8:30 AM EDT - 10 months ago

ICON plc to Present at the William Blair 45th Annual Growth Stock Conference

ICON releases its ICON Cares 2024 Report

May 19, 2025, 4:15 PM EDT - 10 months ago

ICON releases its ICON Cares 2024 Report

Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies

May 7, 2025, 7:27 AM EDT - 11 months ago

Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies

ICON Public Limited Company (ICLR) Q1 2025 Earnings Call Transcript

May 2, 2025, 2:42 AM EDT - 11 months ago

ICON Public Limited Company (ICLR) Q1 2025 Earnings Call Transcript

ICON Reports First Quarter 2025 Results

Apr 30, 2025, 4:15 PM EDT - 11 months ago

ICON Reports First Quarter 2025 Results

OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 13 at 1:01 PM
$ICLR RSI: 46.96, MACD: -11.2775 Vol: 8.03, MA20: 102.24, MA50: 147.68 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
erevnon
erevnon Mar. 11 at 4:07 PM
Citigroup maintains Icon $ICLR at Neutral and lowers the price target from $200 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
anachartanalyst
anachartanalyst Mar. 9 at 3:02 PM
$ICLR https://anachart.com/wp-content/uploads/ana_temp/1773068494_soc-img.jpg
0 · Reply
Rogue23
Rogue23 Mar. 6 at 5:33 PM
$ICLR Earnings today?
0 · Reply
2sexyBiatch
2sexyBiatch Mar. 6 at 6:22 AM
$ICLR still waiting for $150
0 · Reply
sandeeprk
sandeeprk Feb. 23 at 4:49 PM
$ICLR steadily and slowly it will reach 160+
0 · Reply
PittsburghTrader
PittsburghTrader Feb. 23 at 4:28 PM
$ICLR back > $100, nice… that crash on small acctg issue was certainly nice buying opportunity
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 20 at 3:01 AM
$ICLR Share Price: $98.27 Contract Selected: Jul 17, 2026 $100 Calls Buy Zone: $11.81 – $14.60 Target Zone: $20.32 – $24.83 Potential Upside: 62% ROI Time to Expiration: 147 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 19 at 7:48 PM
$ICLR RSI: 20.84, MACD: -23.4293 Vol: 38.53, MA20: 149.76, MA50: 170.62 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
apux
apux Feb. 19 at 5:55 PM
$ICLR - why does it feel like this should be getting a buyout offer at $180 right now?
0 · Reply
Henskblueeyes
Henskblueeyes Feb. 19 at 4:36 PM
$ICLR this one is very good. Should be above 120 for starters and then +135
0 · Reply
sandeeprk
sandeeprk Feb. 19 at 3:32 PM
$ICLR
0 · Reply
sandeeprk
sandeeprk Feb. 19 at 3:31 PM
$ICLR it’s oversold and will be back above 130+ with no bad news and 165+ with some good news.
1 · Reply
apux
apux Feb. 19 at 2:48 PM
$ICLR - I would be adding every pull in until this is back over $135+
1 · Reply
BillionerOfKing
BillionerOfKing Feb. 19 at 10:56 AM
$ICLR Current Stock Price: $96.47 Contracts to trade: $95.0 ICLR Feb 20 2026 Call Entry: $3.15 Exit: $5.85 ROI: 86% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
silkroad58
silkroad58 Feb. 18 at 11:38 PM
$CCJ $NBIS $ICLR $GKOS $SPY Your picks are a day late and a dollar short. Blocked
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Feb. 18 at 6:11 PM
$ICLR
0 · Reply
stockpicker63
stockpicker63 Feb. 18 at 3:34 PM
Whatch today ! $CCJ (Top), $NBIS, $ICLR, $GKOS
0 · Reply
theflynews
theflynews Feb. 18 at 10:45 AM
Icon just upgraded at TD Cowen, here's why - $ICLR - https://legacy.thefly.com/permalinks/entry.php/id4294669
0 · Reply
koditrump
koditrump Feb. 17 at 9:39 PM
$DJT $HIVE $ICLR
0 · Reply
Sw1ngb0t
Sw1ngb0t Feb. 17 at 3:12 PM
$INLF $RPGL $VTAK $BKKT $ICLR
0 · Reply